4//SEC Filing
Chereau Frederic 4
Accession 0001209191-22-015772
CIK 0001664106other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 5:54 PM ET
Size
9.4 KB
Accession
0001209191-22-015772
Insider Transaction Report
Form 4
Chereau Frederic
DirectorPresident, CEO
Transactions
- Award
Stock Option (right to buy)
2022-03-01+328,000→ 328,000 totalExercise: $0.70Exp: 2032-03-01→ Common Stock (328,000 underlying)
Footnotes (2)
- [F1]The options were granted by LogicBio Therapeutics, Inc. (the "Company") pursuant to its 2018 Equity Incentive Plan.
- [F2]The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Company on each vesting date.
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001640592
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 5:54 PM ET
- Size
- 9.4 KB